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Chronic kidney disease (CKD) in cystic ﬁbrosis is becoming increasingly recog-
nized. Formal methods to measure glomerular ﬁltration rate (GFR) are cumbersome.
A rapid, minimally-invasive method of measuring GFR would be useful.
Methods: GFR was measured using Cr51EDTA in stable CF patients. Serum
creatinine and cystatin C, and a urinary biomarker panel (including KIM1, NAG,
Il-18, NGAL and cystatin C) were assayed. GFR was estimated using creatinine
(Schwartz formula for children; MDRD formula for adults) and cystatin C based
formulas (MacIsaac and Larsson). Bland-Altman plots were used to evaluate
agreement. Received operator characteristic (ROC) plots were used to evaluate the
ability of estimated GFR and urinary biomarkers to classify patients as stage II
CKD or worse (GFR <90ml/min/1.73m2).
Results: GFR and creatinine were measured in 67 patients (51 children and 16
adults); biomarkers were available for 63 patients. GFR was low (Stage II CKD;
<90ml/min/1.73m2) in 6/67 (9.0%) of patients. Creatinine and cystatin C based
formulas for predicting GFR performed poorly (see table). KIM-1 performed best
at predicting low GFR (sensitivity 83% and speciﬁcity 72%).
Table 1
Formula/test Bias 95% limits of agreement ROC AUC
MacIsaac 1.2 −53.51 to 55.9 0.655
Larsson −1.6 −66.7 to 63.3 0.649
Creatinine eGFR −5.85 −58.3 to 46.6 0.664
KIM1 Not applicable Not applicable 0.747
Conclusions: Creatinine and cystatin C based formulas perform poorly at predicting
low GFR in cystic ﬁbrosis. KIM1 shows promise as a screening test for low GFR.
